Multilac Care and SLINTEC unveil antibacterial spray to fight Coronavirus | Sunday Observer

Multilac Care and SLINTEC unveil antibacterial spray to fight Coronavirus

28 February, 2021
COO of SLINTEC, Heminda Jayaweera (on left) with Director and CEO of Multilac Care, Mizha Mizver Ismail.
COO of SLINTEC, Heminda Jayaweera (on left) with Director and CEO of Multilac Care, Mizha Mizver Ismail.

Multilac Care  and the Sri Lanka Institute of Nanotechnology (SLINTEC) launched an antiviral and antibacterial spray recently.

Surfaces sprayed with Novid antiviral and antibacterial spray have been tested to reveal that the coating can kill 99% of harmful microbes including the Coronavirus. It has been tested and certified by the Virology Research Services Labs in London, UK, a company spokesman said.

Director and CEO of Multilac Care, Mizha Mizver Ismail said, “We have been working with SLINTEC to develop an effective solution in proactively fighting the Coronavirus.  Novid antiviral and antibacterial spray is the outcome of our collaboration and it has proved to be highly effective against the Coronavirus with the anti-viral technology used in its manufacturing process.” SLINTEC Chief of Research and Innovation, Dr. Azeez Mubarak said, “Innovation has always been a key factor in economic growth of successful nations. But to translate research results to economic returns, active collaboration between R&D institutes and industry is a must. And Novid, the result of a fruitful partnership between SLINTEC and Multilac care is a prime example in this regard.”

To get the maximum benefit from the spray and for easy application, users need to ensure that the surface is clean and dry, and shake well before spraying. Users are also advised to follow  health guidelines as the Novid spray alone will not assure 100% protection from Covid-19. 

Comments